Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-09-01 Rawcliffe Adrian Chief Executive Officer Sale −2,536 $1.97 $5K 3,316
2022-06-27 Rawcliffe Adrian Chief Executive Officer Sale −2,562 $1.63 $4K 3,290
2022-01-18 Rawcliffe Adrian Chief Executive Officer Sale −11,096 $3.19 $35K 12,312
2022-01-12 Rawcliffe Adrian Chief Executive Officer Sale −3,046 $3.54 $11K 3,356
2022-01-12 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +4,690,224 4,690,224
2022-01-12 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +1,047,480 1,047,480
2022-01-11 Rawcliffe Adrian Chief Executive Officer Sale −14,362 $3.56 $51K 15,978
2022-01-04 Rawcliffe Adrian Chief Executive Officer Sale −5,532 $4.06 $22K 6,172
2021-09-01 Rawcliffe Adrian Chief Executive Officer Sale −2,782 $5.20 $14K 3,070
2021-06-28 Rawcliffe Adrian Chief Executive Officer Sale −2,794 $4.37 $12K 3,058
2021-01-19 Rawcliffe Adrian Chief Executive Officer Sale −9,879 $5.67 $56K 13,529
2021-01-12 Rawcliffe Adrian Chief Executive Officer Sale −2,707 $6.15 $17K 3,695
2021-01-11 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +3,260,400 3,260,400
2021-01-11 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +728,160 728,160
2021-01-04 Rawcliffe Adrian Chief Executive Officer Sale −4,967 $5.33 $26K 6,737
2020-09-01 Rawcliffe Adrian Chief Executive Officer Sale −2,776 $8.51 $24K 3,076
2020-08-03 Rawcliffe Adrian Chief Executive Officer Sale −2,788 $9.25 $26K 3,064
2020-01-16 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +2,515,536 2,515,536
2020-01-16 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +561,792 561,792
2020-01-14 Rawcliffe Adrian Chief Executive Officer Sale −3,236 $5.13 $17K 3,166

Page 2 of 3 · 53 trades